Home › Funds › McCarthy Asset Management, Inc. › TTRX
McCarthy Asset Management, Inc. position in TTRX
TURN THERAPEUTICS INC · Health Care
McCarthy Asset Management, Inc. reported holding 15,018 shares of TTRX (TURN THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$216K, representing 0.10% of its reported portfolio and ranking #27 among its reported holdings. McCarthy Asset Management, Inc. has disclosed TTRX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-10-20 · Source: SEC EDGAR Form 13F-HR
How McCarthy Asset Management, Inc.'s TTRX position evolved
McCarthy Asset Management, Inc. first disclosed a stake in TTRX in Q2 2026 at 15,018 shares (US$110K). The position peaked in Q3 2026 at 15,018 shares, worth US$216K. Across 2 filings, McCarthy Asset Management, Inc. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 15,018 shares valued at US$216K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 15.02K | $109.63K | New |
| Q3 2026 | 15.02K | $216.11K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TTRX and 13F data
TTRX (TURN THERAPEUTICS INC) is a Health Care company. 31 other funds we track also report a position in TTRX — the largest reported positions include DDFG, Inc (US$1.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on McCarthy Asset Management, Inc.
FAQ
How long has McCarthy Asset Management, Inc. held TTRX?
McCarthy Asset Management, Inc. has disclosed TTRX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is McCarthy Asset Management, Inc.'s current position in TTRX?
As of Q3 2026, McCarthy Asset Management, Inc. holds 15.02K shares of TTRX (TURN THERAPEUTICS INC), valued at $216.11K, representing 0.10% of its reported portfolio and ranking #27.
Has McCarthy Asset Management, Inc. been buying or selling TTRX?
In the latest 13F filing (Q3 2026), McCarthy Asset Management, Inc. held unchanged its position in TTRX. The position peaked in Q3 2026 at 15.02K shares.
Which other funds hold TTRX?
Other major institutional holders of TTRX include DDFG, Inc, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.